Tag:
Angiotech Pharmaceuticals
Latest Headlines
Latest Headlines
Canada's Angiotech files for bankruptcy protection
Canada's Angiotech will file for bankruptcy protection under Canada's Companies' Creditors Arrangement Act. The recapitalization move is expected to end with the elimination of Angiotech's $250
Angiotech enters distribution pact with B. Braun
Angiotech Pharmaceuticals, a specialty pharmaceutical and medical device company, has entered an exclusive five-year distribution agreement with B. Braun for its proprietary Quill SRS product line in
Angiotech faces tough choices as losses swell
After taking a writedown on goodwill, Angiotech Pharmaceuticals reported a fourth quarter loss that swelled to $77 million--up from $27.9 million from the year before. The Canadian biotech also
Angiotech cuts jobs, shutters facilities
Canada's Angiotech Pharmaceuticals is restructuring its operations as a badly needed investment of up to $300 million appears to be in doubt now. Ares Management and New Leaf Venture Partners had
SPOTLIGHT: Angiotech suspends trial
Angiotech suspends trialAngiotech is suspending clinical trials for its Vascular Wrap product candidate in patients undergoing surgery for hemodialysis access, pending a safety review to evaluate an
ALSO NOTED: Synovics raises cash, buys Kirk; Angiotech buys Quill Medical; and much more...
> Phoenix-based Synovics Pharmaceutical has raised $21.2 million in new financing and purchased the generic drug maker Kirk Pharmaceuticals for $12 million. Report > Angiotech Pharmaceuticals
Angiotech to acquire AMI in $785M buyout
Angiotech Pharmaceuticals will fork over $785 million in cash to acquire American Medical Instruments, which makes needles and surgery tools. For Angiotech, the deal will allow it to expand on its
